Afatinib Dimaleate Yepakati CAS 314771-76-1 Kuchena > 99.0% (HPLC) Factory

Tsanangudzo Pfupi:

Kemikari Zita: (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine

CAS: 314771-76-1

Kuchena:> 99.0% (HPLC)

Chitarisiko: Yero Yero kusvika Yero Upfu

Pakati peAfatinib Dimaleate (CAS: 850140-73-7)

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name (S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine
Mashoko anoreva zvakafanana N4-(3-Chloro-4-Fluorophenyl) -7-[[(3S)-Tetrahydro-3-Furanyl]oxy] -4,6-Quinazolinediamine;Afatinib Kusachena B;Afatinib-des(4-Dimethylamino-2-en-1-oxo)butyl;Des(4-Dimethylamino-2-en-1-oxo)butyl Afatinib
Nhamba yeCAS 314771-76-1
Nhamba yeCAT RF-PI2028
Stock Status MuStock, Kugadzira Kugona 100MT/Gore
Molecular Formula C18H16ClFN4O2
Molecular Weight 374.8
Boiling Point 559.0±50.0℃
Density 1.473±0.060 g/cm3
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko Yero Yero kusvika Yero Hupfu
Identification Iyo Nguva Yekuchengeta YePrincipal Peak muHPLC Inofanirwa Kuenderana neChiyero
Kuchena / Analysis Method >99.0% (HPLC)
Kurasika paKuomesa <0.50%
Residue paIgnition <0.20%
Kusachena Kumwechete <0.50%
Zvose Zvisina Kuchena <1.00%
Heavy Metals (as Pb) ≤20ppm
Test Standard Enterprise Standard
Usage Pakati peAfatinib Dimaleate (CAS: 850140-73-7)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro

Zvakanakira:

1

FAQ:

Application:

(S)-N4-(3-Chloro-4-Fluorophenyl)-7-((Tetrahydrofuran-3-yl)oxy)quinazoline-4,6-Diamine (CAS: 314771-76-1) iri pakati peAfatinib Dimaleate. (CAS: 850140-73-7).Afatinib chizvarwa chechipiri chine simba uye chisingachinjiki chechipiri inhibitor ye epidermal growth factor receptor (EGFR) uye epidermal growth factor receptor 2 (HER2) tyrosine kinase, yakagadzirwa naBoehringer Ingelheim, Germany.Iyo inokwanisa kuvharidzira zvisingachinjiki basa re tyrosine kinase kuburikidza nekuita Michael reaction ne thiol group ye cysteine ​​​​panzvimbo 797 yeEGFR.Basa: 1. Kufanana neLapatinib neNeratinib, Afatinib iprotein kinase inhibitor iyo inodzivisawo irreversibly inhibits epidermal growth factor receptor 2 (Her2) uye epidermal growth factor receptor (EGFR) kinases.2. Afatinib haisi kungoshanda chete kurwisana neEGFR kuchinja kunotarirwa nevekutanga veTKIs se erlotinib kana gefitinib, asiwo kunopesana nekuchinja kwakafanana neT790M iyo isinganzwisisi kune aya maitiro ekurapa.Nekuda kwebasa rayo rekuwedzera kurwisa Her2, iri kuongororwa gomarara rezamu pamwe nemamwe EGFR uye Her2 inofambiswa negomarara.3. Afatinib mushonga wekurapa mutsara wekutanga wevarwere vane mhando dzakasiyana dze metastatic (EGFR mutation positive) isiri-small cell lung carcinoma (NSCLC).Inoshanda sechinhu chisingachinjiki covalent inhibitor ye receptor tyrosine kinases epidermal growth factor receptor (EGFR) uye erbB-2 (HER2).

Nyora meseji yako pano uye titumire kwatiri